產(chǎn)品詳情
簡(jiǎn)單介紹:
Leflunomide
詳情介紹:
Purpose | Leflunomide is a pyrimidine synthesis inhibitor belonging to the DMARD (disease-modifying antirheumatic drug) class of drugs, which are chemically and pharmacologically very heterogeneous. Leflunomide was approved by FDA and in many other countries (e.g., Canada, Europe) in 1999. |
Characteristics |
Tradename: ARAVA Source of Compound: synthetic, SU-101, HWA-486 Target: Protein-tyrosine kinase 2 antagonist,AhR agonist,Dehydrogenase inhibitor Receptor: Protein-tyrosine kinase 2,AhR,DHODH Status: USAN, INN, BAN |
Purification | All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality. |
Purity | 99?% |
Formula | C12H9F3N2O2 |
Solubility | Soluble in DMSO |
Molecular Weight | 270.21 g/mol |
CAS-No | 75706-12-6 |
Application Notes | Optimal working dilution should be determined by the investigator. |
Restrictions | For Research Use only |
Format | Solid |
Storage | -20 °C |
Storage Comment |
For the majority of compounds, they could be dissolved in DMSO or other organic solvent. Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience. Several freeze/thaw cycles should not damage the activity of our small molecule products. However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours. |
Expiry Date | 24 months |